Effectiveness of Disease-Modifying Antirheumatic Drugs for Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort

REFERENCES

1. 1.↵
   1. Alinaghi F,
   2. Calov M,
   3. Kristensen LE, et al.

   Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 2019;80:251–65.

   OpenUrlPubMed
2. 2.↵
   1. Ritchlin CT,
   2. Colbert RA,
   3. Gladman DD.

   Psoriatic arthritis. N Engl J Med 2017;376:957–70.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Rida MA,
   2. Chandran V.

   Challenges in the clinical diagnosis of psoriatic arthritis. Clin Immunol 2020;214:108390.

   OpenUrl
4. 4.↵
   1. Schett G,
   2. Lories RJ,
   3. D’Agostino MA, et al.

   Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol 2017;13: 731–41.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Mease PJ,
   2. Karki C,
   3. Palmer JB, et al.

   Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Arthritis Care Res 2017;69:1692–9.

   OpenUrlPubMed
6. 6.↵
   1. Polachek A,
   2. Li S,
   3. Chandran V,
   4. Gladman DD.

   Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: incidence, prevalence, characteristics, and outcome. Arthritis Care Res 2017;69:1685–91.

   OpenUrlPubMed
7. 7.↵
   1. Taylor W,
   2. Gladman D,
   3. Helliwell P,
   4. Marchesoni A,
   5. Mease P,
   6. Mielants H; CASPAR Study Group

   . Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665–73.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Kavanaugh A,
   2. Helliwell P,
   3. Ritchlin CT.

   Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Rheumatol Ther 2016;3:91–102.

   OpenUrl
9. 9.↵
   1. Polachek A,
   2. Cook R,
   3. Chandran V,
   4. Gladman DD,
   5. Eder L.

   The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Res Ther 2017;19:189.

   OpenUrlPubMed
10. 10.↵
    1. Mease P.

    Enthesitis in psoriatic arthritis (Part 3): clinical assessment and management. Rheumatology 2020;59 Suppl 1:i21–8.

    OpenUrlPubMed
11. 11.↵
    1. Orbai AM,
    2. de Wit M,
    3. Mease P, et al.

    International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis 2017;76:673–80.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Singh JA,
    2. Guyatt G,
    3. Ogdie A, et al.

    2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheum 2019;71:5–32z.

    OpenUrl
13. 13.↵
    1. Gossec L,
    2. Baraliakos X,
    3. Kerschbaumer A, et al.

    EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020;79:700–12.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Coates LC,
    2. Kavanaugh A,
    3. Mease PJ, et al.

    Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 2016;68:1060–71.

    OpenUrlPubMed
15. 15.↵
    1. Kerschbaumer A,
    2. Smolen JS,
    3. Dougados M, et al.

    Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 2020;79:778–86.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Gladman DD,
    2. Chandran V.

    Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology 2011;50:25–31.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Chandran V,
    2. Schentag CT,
    3. Gladman DD.

    Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2007;57:1560–3.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Mease PJ,
    2. Van den Bosch F,
    3. Sieper J,
    4. Xia Y,
    5. Pangan AL,
    6. Song I.

    Performance of 3 enthesitis indices in patients with peripheral spondyloarthritis during treatment with adalimumab. J Rheumatol 2017;44:599–608.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Mackenzie H,
    2. Thavaneswaran A,
    3. Chandran V,
    4. Gladman DD.

    Patient-reported outcome in psoriatic arthritis: a comparison of web-based versus paper-completed questionnaires. J Rheumatol 2011;38:2619–24.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Maksymowych WP,
    2. Mallon C,
    3. Morrow S, et al.

    Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 2009;68:948–53.

    OpenUrlAbstract/FREE Full Text
21. 21.
    1. Heuft-Dorenbosch L,
    2. Spoorenberg A,
    3. van Tubergen A, et al.

    Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003;62:127–32.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Healy PJ,
    2. Helliwell PS.

    Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 2008;59:686–91.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Pittam B,
    2. Gupta S,
    3. Harrison NL,
    4. Robertson S,
    5. Hughes DM,
    6. Zhao SS.

    Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology 2020;59:2199–206.

    OpenUrl
24. 24.↵
    1. Carneiro S,
    2. Bortoluzzo A,
    3. Goncalves C, et al.

    Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis. J Rheumatol 2013;40:1719–25.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Araujo EG,
    2. Englbrecht M,
    3. Hoepken S, et al.

    Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. Semin Arthritis Rheum 2019;48:632–37.

    OpenUrlPubMed
26. 26.↵
    1. Mourad A,
    2. Gniadecki R.

    Treatment of dactylitis and enthesitis in psoriatic arthritis with biologic agents: a systematic review and metaanalysis. J Rheumatol 2020;47:59–65.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Kaeley GS,
    2. Schett G,
    3. Conaghan PG, et al.

    Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of EXCEED [abstract]. Ann Rheum Dis 2021;80:311–2.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Mease PJ,
    2. Gladman DD,
    3. Collier DH, et al.

    Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial. Arthritis Rheum 2019;71:1112–24.

    OpenUrl
29. 29.↵
    1. Appani SK,
    2. Devarasetti PK,
    3. Irlapati RVP,
    4. Rajasekhar L.

    Methotrexate achieves major cDAPSA response, and improvement in dactylitis and functional status in psoriatic arthritis. Rheumatology 2019;58:869–73.

    OpenUrl
30. 30.↵
    1. Coates LC,
    2. Helliwell PS.

    Methotrexate efficacy in the Tight Control in Psoriatic Arthritis study. J Rheumatol 2016;43:356–61.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Michelsen B,
    2. Diamantopoulos AD,
    3. Soldal DM,
    4. Hammer HB,
    5. Kavanaugh A,
    6. Haugeberg G.

    Achilles enthesitis defined by ultrasound is not associated with clinical enthesitis in patients with psoriatic arthritis. RMD Open 2017;3:e000486.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Poulsen AEF,
    2. Axelsen MB,
    3. Poggenborg RP, et al.

    Whole-body magnetic resonance imaging in psoriatic arthritis, rheumatoid arthritis, and healthy controls: interscan, intrareader, and interreader agreement and distribution of lesions. J Rheumatol 2021; 48:198–206.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Macchioni P,
    2. Salvarani C,
    3. Possemato N, et al.

    Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis and fibromyalgia syndrome: the ULISSE study. J Rheumatol 2019;46:904–11.

    OpenUrlAbstract/FREE Full Text